- Active not recruitingPHASE3
BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer
This study looks at treating high-risk bladder cancer that hasn't spread into the bladder muscle. It combines two existing treatments, BCG and Mitomycin, to see if using them together is more effective at stopping the cancer from coming back.
For: Transitional Cell Carcinoma · Transurethral ResectionUnited Kingdom - Ongoing, recruitingTherapeutic confirmatory (Phase III)
Intravesical Mistletoe Extract in Superficial Bladder Cancer: A Phase III Efficacy Study
This study looks at a mistletoe extract treatment for early-stage bladder cancer. It compares it to standard treatments to see if it can stop the cancer from coming back. Doctors want to find out how well it works and if it's safe for patients.
Germany - AuthorisedTherapeutic confirmatory (Phase III)
Efficacy of the use of neoadjuvant with/without hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced colon cancer: A phase III multi-arm, randomized and controlled clinical trial (FOXHIPECT4)
This study is testing different ways to treat advanced colon or upper rectal cancer. It looks at adding a special heated chemotherapy wash to standard treatment during surgery to see if it helps people live longer without the cancer coming back. The aim is to find the best treatment.
Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
SPARTANA : Spartalizumab, mDCF (docetaxel, cisplatin and 5-fluorouracil) and radiotherapy in patients with metastatic squamous cell anal carcinoma. A Phase IIA study
This study is testing new treatments for a type of cancer called anal cancer that has spread. It combines existing chemotherapy with an investigational drug and radiotherapy to see if patients live longer without their cancer getting worse.
For: metastatic squamous cell anal carcinomaFrance